Left Atrial Reverse Remodeling in Dilated Cardiomyopathy

Vincenzo Nuzzi, Anne Raafs, Paolo Manca, Michiel T H M Henkens, Caterina Gregorio, Andrea Boscutti, Job Verdonschot, Mark Hazebroek, Christian Knackstedt, Marco Merlo, Davide Stolfo*, Gianfranco Sinagra, Stephane R B Heymans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


BACKGROUND: Left atrial (LA) dilation is associated with a worse prognosis in several cardiovascular settings but therapies can promote LA reverse remodeling. We aimed to characterize and define the prognostic implications of LA volume (LAVI) reduction in dilated cardiomyopathy (DCM).

METHODS: Consecutive DCM patients from two tertiary care centers, with available echocardiography at baseline and at 1-year follow-up, were retrospectively analyzed. LA dilation was defined as LAVI >34 ml/m2, change in LAVI (ΔLAVI) was defined as the 1-year relative LAVI reduction. The outcome was a composite of death/heart transplantation/heart failure hospitalization (D/HTx/HFH).

RESULTS: Five hundred sixty patients were included (age 54±13 years; left ventricular ejection fraction (LVEF) 31±10%, LAVI 45±18 ml/m2). Baseline LAVI had a non-linear association with the risk of D/HTx/HFH, independently from age, LVEF, MR and medical therapy (p<0.01). At 1-year follow-up, LAVI decreased in 374 patients (67%, median ΔLAVI -24%, interquartile range -37% - -11%). Factors independently associated with ΔLAVI were higher baseline LAVI and lower baseline LVEF. After multivariable adjustment, ΔLAVI showed a linear association with the risk of D/HTx/HFH (HR 0.96, 95% 0.93-0.99 per 5% decrease, p=0.042). At 1-year follow-up, patients with a reduction in LAVI greater than 10% and LAVI normalization (i.e. follow-up LAVI ≤34ml/m2) (31% of the overall cohort) were at lower risk of D/HTx/HFH (HR 0.37, 95% C.I. 0.35-0.97, p=0.028).

CONCLUSIONS: In a large cohort of DCM, 1-year reduction in LAVI is observed in a number of patients. The association between reduction in LAVI and D/HTx/HFH suggests that LA structural reverse remodeling might be considered an additional parameter useful in the individualized risk stratification of patients with DCM.

Original languageEnglish
Pages (from-to)154-162
JournalJournal of the American Society of Echocardiography
Issue number2
Early online date1 Nov 2022
Publication statusPublished - Feb 2023


Dive into the research topics of 'Left Atrial Reverse Remodeling in Dilated Cardiomyopathy'. Together they form a unique fingerprint.

Cite this